Selective serotonin reuptake inhibitors and the risk of acute pancreatitis: A swedish population-based case-control study

Journal of Clinical Psychopharmacology

Volumn 32, Issue 3, 2012, Pages 336-340

  Ljung, Rickard ^a   Rück, Christian ^a   Mattsson, Fredrik ^a   Bexelius, Tomas Sjöberg ^a   Lagergren, Jesper ^a,b   Lindblad, Mats ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

alcohol; amylase; depression; gallstone; pharmacoepidemiology; selective serotonin reuptake inhibitors; smoking

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ACUTE PANCREATITIS; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; EDUCATIONAL STATUS; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OBESITY; PAIN; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SMOKING; SWEDEN;

ACUTE DISEASE; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PANCREATITIS; REGISTRIES; RISK; SEROTONIN UPTAKE INHIBITORS; SWEDEN; TIME FACTORS;

EID: 84861019156     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318253d71a     Document Type: Article

References (23)

1. Appelros S, Borgstrom A. Incidence, aetiology and mortality rate of acute pancreatitis over 10 years in a defined urban population in Sweden. Br J Surg. 1999;86(4):465-470.
2. Kvande KT, Madsen S. Selective serotonin uptake inhibitors and pancreatitis [in Norwegian]. Tidsskr Nor Laegeforen. 2001;121(2):177-178.
3. Malbergier A, de Oliveira Junior HP. Sertraline and acute pancreatitis: A case-report [in Portuguese]. Rev Bras Psiquiatr. 2004;26(1):39-40.
4. Spigset O, Hagg S, Bate A. Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitors: Data from theWorld Health Organization (WHO) database of adverse drug reactions. Int Clin Psychopharmacol. 2003;18(3):157-161.
5. Kirchgessner AL, Gershon MD. Presynaptic inhibition by serotonin of nerve-mediated secretion of pancreatic amylase. Am J Physiol. 1995;268(2 Pt 1):G339-G345.
6. Li Y, Wu XY, Zhu JX, et al. Intestinal serotonin acts as paracrine substance to mediate pancreatic secretion stimulated by luminal factors. Am J Physiol Gastrointest Liver Physiol. 2001;281(4):G916-G923.
7. Masuda M, Miyasaka K, Funakoshi A. Involvement of 5-hydroxytryptamine (5-HT)3 receptor mechanisms in regulation of basal pancreatic secretion in conscious rats. J Auton Nerv Syst. 1997;62(1-2):58-62.
8. Coulie B, Tack J, Bouillon R, et al. 5-Hydroxytryptamine-1 receptor activation inhibits endocrine pancreatic secretion in humans. Am J Physiol. 1998;274(2 Pt 1):E317-E320.
9. Yoshino T, Yamaguchi I. Possible involvement of 5-HT2 receptor activation in aggravation of diet-induced acute pancreatitis in mice. J Pharmacol Exp Ther. 1997;283(3):1495-1502.
10. Nitsche CJ, Jamieson N, Lerch MM, et al. Drug induced pancreatitis. Best Pract Res Clin Gastroenterol. 2010;24(2):143-155.
11. Wettermark B, Hammar N, Fored CM, et al. The new Swedish Prescribed Drug RegisterVopportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726-735.
12. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, et al. The Swedish personal identity number: Possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24(11):659-667.
13. Rosen M. National Health Data Registers: A Nordic heritage to public health. Scand J Public Health. 2002;30(2):81-85.
14. Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.
15. World Health Organization. WHO Collaborating Centre for Drug Statistics Methodology. Geneva, Switzerland: World Health Organization. Available at: Http://www.whocc.no/atcddd/. Accessed June 16, 2011.
16. Socialstyrelsen. Cancer Incidence in Sweden 2009. Stockholm, Sweden: The National Board of Health and Welfare; 2010. Available at: Http://www. socialstyrelsen.se/publikationer2010/2010-12-17. Accessed June 16, 2011.
17. Socialstyrelsen. Causes of Death in Sweden 2009. Stockholm, Sweden: The National Board of Health and Welfare; 2010. Available at: Http://www. socialstyrelsen.se/publikationer2011/2011-3-22. Accessed June 16, 2011.
18. Statistics Sweden. Main Outlines for Organization of Population Statistics. Stockholm, Sweden: Statistics; 2007. Available at: Http://www.scb.se/statistik/-publikationer/BE0101-2007A01-BR-19-BE0108TAB.pdf. Accessed June 16, 2011.
19. Statistics Sweden. The Swedish Register of Education. Stockholm, Sweden: Statistics; 2004. Available at: Www.scb.se/statistik/UF/UF0506/ Produktbeskrivning-short-English-UF0506-20040101r.doc. Accessed June 16, 2011.
20. Razavi D, Ljung R, Lu Y, et al. Reliability of acute pancreatitis diagnosis coding in a National Patient Register: A validation study in Sweden. Pancreatology. 2011;11:525-532.
21. Lancashire RJ, Cheng K, Langman MJ. Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis. Aliment Pharmacol Ther. 2003;17(7):887-893.
22. Norgaard M, Jacobsen J, Gasse C, et al. Selective serotonin reuptake inhibitors and risk of acute pancreatitis: A population-based case-control study. J Clin Psychopharmacol. 2007;27(3):259-262.
23. Blomgren KB, Sundstrom A, Steineck G, et al. A Swedish case-control network for studies of drug-induced morbidityVacute pancreatitis. Eur J Clin Pharmacol. 2002;58(4):275-283.